Hämeenkyrö MSWI risk assessment: Indicators: Difference between revisions

From Opasnet
Jump to navigation Jump to search
Line 306: Line 306:
}}
}}


==== PM<sub>2.5</sub> exposure-response function on population level====


{{var
|Name        = PM<sub>2.5</sub> exposure-response function on population level
|Focus      = Describes the relationship between ambient concentrations of PM<sub>2.5</sub> and the frequency of specific health effects in a given timeperiod
|Scope      = General population average considered
|Description = '''PM<sub>2.5</sub>''' are fine particles less than 2.5 μm in diameter.
Concentration-response function is needed when we determine the health impact of PM2.5  concentrations in Hämeenkyrö on local people. Health impact of PM concentrations in Hämeenkyrö = concentration *concentration response.
Concentration-response function needs data from exposure modelling, animal toxicology, small clinical or panel studies, and epidemiological studies.
Exposed population can be subdivided to subpopulations (adults, children, infants, elder people).
Exposure is assessed in a certain timeperiod (daily, annual exposure). 
*Health effects related to '''short-term exposure'''
**respiratory symptoms
**adverse cardiovascular effects
**increased medication usage
**increased number of hospital admissions
**increased mortality
*Health effects related to '''long-term exposure''' (more relevance to public health)
**increased incidence of respiratory symptoms
**reduction in lung function
**increased incidence of chronic obstructive pulmonary disease (COPD)
**reduction in life expectancy
***increased cardiopulmonary mortality
***increased lung cancer mortality
Sensitive subgroups: children, the elderly, individuals with heart and lung disease, individuals who are active outdoors
|Inputs      = Fine particle variables:
*PM<sub>2.5</sub> emissions in Hämeenkyrö
*PM<sub>2.5</sub> emissions from MSWI, biofuel plant, and natural gas plant in Hämeenkyrö
*Baseline PM<sub>2.5</sub> exposure in Hämeenkyrö
*PM<sub>2.5</sub> exposure due to MSWI in Hämeenkyrö
|Index      =
|Definition  =
|Unit        = increase in adverse health effect/ 1 ug/m3 change in PM <sub>2.5</sub> concentration
increase in the risk of death per each 10 µg/m<sup>3</sup> elevation in PM<sub>2.5</sub>
|Result      = PM<sub>2.5</sub>
*6% increase in the risk of deaths from all causes (95% CI 2-11%)
*12% increase in the risk of death from cardiovascular diseases and diabetes (95% CI 8-15%)
*14% increase in the risk of death from lung cancer (95% CI 4-23%)
per each 10 µg/m<sup>3</sup> elevation in PM<sub>2.5</sub> air pollution
|References  = Health aspects of air pollution. Results from the WHO project "Systematic review of health aspects of air pollution in Europe". World Health Organization, 2004. http://www.euro.who.int/document/E83080.pdf
Pope et al. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287(9), 1132-1141.
Pope et al. 2004. Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation (109), 71-77.
Service Contract for Carrying out Cost-Benefit Analysis of Air Quality Related Issues, in particular in the Clean Air for Europe (CAFE) Programme. Volume 2: Health Impact Assessment. AEA Technology Environment, 2005. http://ec.europa.eu/environment/air/cafe/pdf/cba_methodology_vol2.pdf
http://es.epa.gov/ncer/rfa/2004/2004_pm_research.html
}}


====Health effects of dioxins and PM<sub>2.5</sub> ====
====Health effects of dioxins and PM<sub>2.5</sub> ====

Revision as of 17:21, 25 September 2006

See the main page of this assessment: Hämeenkyrö MSWI risk assessment: General

  • Decisions related to Hämeenkyrö case
  • Possible indicators (optimising variables) in Hämeenkyrö

Well-being of the population (smells, comfort, noise)

Kari Auri

Effects on economy (esp. gas energy plant)

Juha

Transportation costs of waste

Dioxin exposure-response function on population level

Anu T


Health effects of dioxins and PM2.5

Anu T